Thyroid cancer management is revolving rapidly, to a more minimalistic, individualized approach for low-risk patients, and to more-targeted and evidence-based therapeutic approaches for advanced-stage disease.

Lower cisplatin dosage may not affect medulloblastoma survival
Although credited with boosting survival rates for children with medulloblastoma, cisplatin-based adjuvant chemotherapy carries significant risks. Research at Mayo Clinic shows no significant differences in event-free survival and overall survival among patients who receive varying cumulative cisplatin doses.

Research has shown that tuft cells act as tumor-initiating cells for pancreatic neoplasia. Now, Mayo Clinic researchers have found that SOX17 expression, both alone and combined with the KRAS oncogene, greatly increases this tumor-initiating ability.

RNA sequencing is used with increasing frequency to characterize a growing array of conditions. A study by 150 researchers in 12 countries found agreement across RNA genomic sequencing techniques and laboratories and ways to improve what little variability exists to set a new high standard.

Clinical and Multidisciplinary Hematology and Oncology 2015: The 12th Annual Review
Jan. 23-25, 2015, in Scottsdale, Ariz.
This comprehensive update of issues in hematologic and oncologic malignancies presents new disease classification, treatment and challenging cases. Topics include hematologic diseases such as dysproteinemias, acute and chronic leukemias and lymphomas, plus supportive, ancillary and diagnostic care.

Mayo Clinic Hematology Review
Jan. 24, 2015, in Minneapolis
Programming provides hematology and oncology clinicians, nurse practitioners, and physician assistants with an overview of advances in the treatment of various hematologic malignancies, based on abstracts presented at the December 2014 annual meeting of the American Society of Hematology.

See all Hematology & Oncology Continuous Professional Development courses

Targeting Improved Survival in Anaplastic Thyroid Cancer
Keith C. Bible, M.D., Ph.D., discusses basic, translational and therapeutic innovations originating at Mayo Clinic and used in the treatment of patients with anaplastic thyroid cancer.

View videos by specialty and Grand Rounds presentations online

• Experimental virus being tested as cancer treatment
  Reuters
• IBM takes on cancer
  NBC News
• Cancer survivor saved by measles virus raises funds for expanded trial
  ABC News
• New test to eradicate colon cancer
  Reuters

• Phoenix/Scottsdale, Arizona
  866-629-6362 (toll-free)
• Jacksonville, Florida
  800-634-1417 (toll-free)
• Rochester, Minnesota
  800-533-1564 (toll-free)
• Online Referrals

• Career Opportunities
• Clinical Trials at Mayo Clinic
• Mayo School of Continuous Professional Development